当前位置:首页 - 行情中心 - 金域医学(603882) - 财务分析 - 现金流量表

金域医学

(603882)

  

流通市值:129.39亿  总市值:130.87亿
流通股本:4.58亿   总股本:4.63亿

现金流量表

报告期2026-06-302026-03-312025-12-312025-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,878,150,699.611,319,687,996.996,803,247,136.154,812,327,401.64
  收到的税费返还2,364,603.89809,257.6778,142,312.6380,133,379.05
  收到其他与经营活动有关的现金65,005,230.0534,251,770.2895,201,861.2481,225,288.35
  经营活动现金流入小计2,945,520,533.551,354,749,024.946,976,591,310.024,973,686,069.04
  购买商品、接受劳务支付的现金1,355,749,257.92621,278,110.893,055,942,868.352,177,622,945.44
  支付给职工以及为职工支付的现金836,763,562.13442,127,689.531,731,876,059.391,243,528,966.87
  支付的各项税费77,669,297.734,492,760.8157,847,532.42133,915,275.8
  支付其他与经营活动有关的现金432,717,947213,420,777.67828,915,582.76746,710,986.45
  经营活动现金流出小计2,702,900,064.751,311,319,338.895,774,582,042.924,301,778,174.56
  经营活动产生的现金流量净额242,620,468.843,429,686.051,202,009,267.1671,907,894.48
二、投资活动产生的现金流量:
  收回投资收到的现金16,106,341.07208,078.1768,673,493.5260,786,632.32
  取得投资收益收到的现金5,074,473.284,912,50011,130,355.57,473,000.81
  处置固定资产、无形资产和其他长期资产收回的现金净额1,830,669.141,650,982.2719,629,787.191,638,438.9
  投资活动现金流入小计23,011,483.496,771,560.4499,433,636.2169,898,072.03
  购建固定资产、无形资产和其他长期资产支付的现金202,324,254.83108,257,591.63423,455,734.18291,845,110.9
  投资支付的现金41,343,534.5834,843,534.5846,950,00040,833,333.34
  投资活动现金流出小计243,667,789.41143,101,126.21470,405,734.18332,678,444.24
  投资活动产生的现金流量净额-220,656,305.92-136,329,565.77-370,972,097.97-262,780,372.21
三、筹资活动产生的现金流量:
  取得借款收到的现金152,808,533.5815,908,533.58221,894,530.96113,745,121.55
  筹资活动现金流入小计152,808,533.5815,908,533.58221,894,530.96113,745,121.55
  偿还债务支付的现金151,815,943.898,425,00087,494,887.7836,422,513.89
  分配股利、利润或偿付利息支付的现金426,682,018.46411,110,545.53434,136,325.29432,424,230.77
  其中:子公司支付给少数股东的股利、利润12,160,000-20,234,928.6914,200,000
  支付其他与筹资活动有关的现金195,236,864.597,976,674.3894,466,022.0538,636,026.08
  筹资活动现金流出小计773,734,826.94427,512,219.91616,097,235.12507,482,770.74
  筹资活动产生的现金流量净额-620,926,293.36-411,603,686.33-394,202,704.16-393,737,649.19
四、汇率变动对现金及现金等价物的影响-19,169,139.0611,117,107.32-13,551,197.53-6,458,287.49
五、现金及现金等价物净增加额-618,131,269.54-493,386,458.73423,283,267.448,931,585.59
  加:期初现金及现金等价物余额2,845,807,817.062,845,807,107.712,422,524,549.622,422,524,549.62
  期末现金及现金等价物余额2,227,676,547.522,352,420,648.982,845,807,817.062,431,456,135.21
补充资料:
  净利润211,621,878.34--178,600,830.71-
  资产减值准备-44,536.78-11,553,941.07-
  固定资产和投资性房地产折旧133,142,995.52-312,534,969.94-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧133,142,995.52-312,534,969.94-
  无形资产摊销8,927,203.13-14,504,323.5-
  长期待摊费用摊销33,459,816.85-88,259,297.34-
  处置固定资产、无形资产和其他长期资产的损失-3,444,177.63--4,398,060.89-
  固定资产报废损失-70,033.92-2,482,860.79-
  公允价值变动损失10,393,882.88-2,124,860.34-
  财务费用6,181,985.05-14,678,676.91-
  投资损失-3,477,813.85--3,838,869.54-
  递延所得税-85,670.7--76,438,932.93-
  其中:递延所得税资产减少1,993,769.25--68,578,384.01-
    递延所得税负债增加-2,079,439.95--7,860,548.92-
  存货的减少177,618.25-12,212,396.4-
  经营性应收项目的减少-71,932,776.14-742,598,880.05-
  经营性应付项目的增加-101,474,400.07--193,553,038.26-
  其他21,794,064.19---
  现金的期末余额2,227,676,547.52-2,845,807,817.06-
  减:现金的期初余额2,845,807,817.06-2,422,524,549.62-
  现金及现金等价物的净增加额-618,131,269.54-423,283,267.44-
公告日期2026-08-252026-04-252026-04-252025-10-30
审计意见(境内)标准无保留意见
TOP↑